BIRC5 regulates inflammatory tumor microenvironment-induced aggravation of penile cancer development in vitro and in vivo

• Main Authors: Li, S. (Author), Liu, S. (Author), Tian, A. (Author), Wan, Y. (Author), Zhang, G. (Author), Zhao, Y. (Author)
• Format: Article
• Language: English
• Published: BioMed Central Ltd 2022
• Subjects: animal; Animals; baculoviral IAP repeat containing protein 5; BIRC5; BIRC5 protein, human; Cell Line, Tumor; cell proliferation; Cell Proliferation; gene expression regulation; Gene Expression Regulation, Neoplastic; genetics; human; Humans; Inflammation; male; Male; Mice; Migration and invasion; mouse; Penile cancer; Penile Neoplasms; penis tumor; Survivin; tumor cell line; tumor microenvironment; Tumor microenvironment; Tumor Microenvironment
• Online Access: View Fulltext in Publisher

 Background: Baculoviral IAP repeat containing 5 (BIRC5) is overexpressed and plays as a key regulator in the progression of various human carcinomas. The inflammatory tumor microenvironment (ITM) is closely associated with the development of cancers. However, the role of BIRC5 in penile cancer (PC) and the ITM-induced abnormal progression of PC is still obscure. Methods: In this study, serum and tissues of patients with PC were recruited to evaluate the expression profile of BIRC5. We used PC cell lines (Penl1 and Penl2) and constructed a PC xenograft mice model to explore the effects of the silencing of BIRC5 on proliferation, migration, invasion and tumor growth, as well as survival of mice. Besides, interferon (IFN)-γ was utilized to mimic the ITM of PC cells. Results: Our results showed that BIRC5 was dramatically upregulated in the serum and tissues of PC patients, as well as PC cell lines. Knockdown of BIRC5 inhibited the proliferation, migration and invasion of PC cells. Meanwhile, it suppressed PC xenograft tumor growth and improved mice survival. Moreover, IFN-γ significantly aggravated PC progression both in vivo and in vitro while the silencing of BIRC5 reversed these unfavorable effects. Conclusions: Taken together, our data revealed that BIRC5 silencing inhibited aggravation of PC cell processes and tumor development induced by ITM. This suggested that BIRC5 may function as a diagnosis and therapy target of PC in the future. © 2022, The Author(s).